This is an exploratory study to further delineate the microenvironment of the PT and (S)LNs in cervical cancer.
ID
Bron
Verkorte titel
Aandoening
Cervical cancer
Lymph nodes
HPV
Cervixcarcinoom
Lymfeklieren
HPV
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
To analyse the microenvironment of (S)LNs and PT (i.e. antigen presenting cells and other immune cells) and other immune<br>
factors produced by the tumour cells in patients with cervical cancer.
Achtergrond van het onderzoek
This is an exploratory study to further delineate the microenvironment of the primary tumour and (sentinel) lymph nodes in cervical cancer.All patients diagnosed with cervical carcinoma who will undergo an operation or a lymphadenectomy will be asked to participate in the study. Patients who will undergo a lymphadenectomy will be asked to participate in detecting the SLNs prior to the lymph node dissection by injecting ICG/patent blue in the tumour before the operation starts in the operation room. Patients who will undergo a lymph node debulking in the context of chemoradiotherapy, will be asked permission to obtain a small tumour biopsy.
Doel van het onderzoek
This is an exploratory study to further delineate the microenvironment of the PT and (S)LNs in cervical cancer.
Onderzoeksopzet
- blood will be drawn before surgery and 3 months after surgery
Onderzoeksproduct en/of interventie
- patients will be asked to give permission to search for sentinel node(s), by injecting patent blue
- patients will be asked to donate 2x 10 ml blood for further analysis (at two different timepoints)
Algemeen / deelnemers
Jossie Rotman
Obstetrics & Gynecology/Immunotherapy Lab
Amsterdam
The Netherlands
(020-44)42175 Mob: +31622706702
Mail: j.rotman@vumc.nl
Wetenschappers
Jossie Rotman
Obstetrics & Gynecology/Immunotherapy Lab
Amsterdam
The Netherlands
(020-44)42175 Mob: +31622706702
Mail: j.rotman@vumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Age ≥ 18 years at start of the study;
- Primary carcinoma of the cervix;
- Operation at the NKI-AVL or AMC/VUmc;
- Signed informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Patients with cervical cancer other than squamous,
adeno- or adenosquamous origin.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6842 |
NTR-old | NTR7020 |
Ander register | NL62567.031.17 : M17GINC |